Business UpdateMay 5, 2026, 04:27 PM
BiomX Pivots to Defense & Security with DFSL, Zorronet Acquisitions
AI Summary
BiomX Inc. has undergone a significant strategic transformation, discontinuing its legacy phage therapy programs and initiating insolvency proceedings for its former Israeli subsidiary. The company has pivoted into the defense, security, and critical infrastructure markets, marked by a complete change in management and board. This new direction includes the acquisition of DR. Frucht Systems Ltd. (DFSL) and Zorro Net Ltd. (Zorronet), and the establishment of a new Israeli subsidiary, X Security & Defense LTD.
Key Highlights
- Discontinued legacy phage therapy programs and ceased all clinical trials.
- Former Israeli operating subsidiary, BiomX Ltd., filed for insolvency proceedings in December 2025.
- Completed a full transition of the Company's management team and Board of Directors.
- Pivoted strategically into the defense, security, and critical infrastructure markets.
- Acquired a controlling interest in DR. Frucht Systems Ltd. (DFSL), a LADAR-based detection systems company.
- Acquired Zorro Net Ltd. (Zorronet), an AI-powered security and command-and-control platform company.
- Established X Security & Defense LTD., a wholly-owned Israeli subsidiary.